Skip to main content
Idorsia Ltd (SWX:IDIA)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
3.620
+0.090 (2.55%)
Mar 9, 2026, 5:31 PM CET

Idorsia Revenue

In the year 2025, Idorsia had annual revenue of 220.58M CHF with 96.06% growth. Idorsia had revenue of 47.97M in the quarter ending December 31, 2025, a decrease of -19.91%.

Revenue
220.58M
Revenue Growth
+96.06%
P/S Ratio
4.13
Revenue / Employee
339.36K
Employees
650
Market Cap
910.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025220.58M108.08M96.06%
Dec 31, 2024112.51M-39.88M-26.17%
Dec 31, 2023152.39M55.28M56.93%
Dec 31, 202297.10M61.75M174.70%
Dec 31, 202135.35M-36.41M-50.74%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Basilea Pharmaceutica AG 232.38M
Newron Pharmaceuticals 55.93M
Santhera Pharmaceuticals Holding AG 49.02M
BioVersys AG 1.31M
Molecular Partners AG 681.00K
Xlife Sciences AG 839.38K
Addex Therapeutics 158.54K
Revenue Rankings

Idorsia News

More News